ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

[PDF]

ACG Clinical Guideline: The Diagnosis and Management of

Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. DILI is a diagnosis of exclusion and thus careful history taking and thorough

Published in: The American Journal of Gastroenterology · 2014Authors: Naga Chalasani · Paul H Hayashi · Herbert L Bonkovsky · Victor J Navarro · William …Affiliation: Indiana University · University of North Carolina at Chapel Hill · Carolinas Healthcare S…

ACG Clinical Guideline: the diagnosis and management of

Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world.

ACG Clinical Guideline: The Diagnosis and Management of

Drug-Induced Liver Disease, 3rd edition is a comprehensive reference that covers mechanisms of injury, diagnosis and management, major hepatotoxins, regulatory perspectives and much more.

[PDF]

ACG Clinical Guideline: The Diagnosis and Management of

PRACTICE GUIDELINES PREAMBLE The wr iting group was invited by the Board of the Trustees and the Practice Parameters Committee of the American College of Gastroenterology to develop a practice guideline regarding the diagnosis and management of idiosyncratic drug-induced liver injury (DILI). The writing group developed this practice

ACG Clinical Guideline: The Diagnosis and Management of

Clinical Guidelines. Authored by a talented group of GI experts, the College is devoted to the development of new ACG guidelines on gastrointestinal and liver diseases. Our guidelines reflect the current state-of-the-art scientific work and are based on the principles of evidence-based medicine.

Diagnosis and Management of Idiosyncratic Drug-Induced

Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950-66.

ACG Clinical Guideline: The Diagnosis and Management of

TABLE 1. FROM: ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Naga P Chalasani, Paul H Hayashi, Herbert L …

ACG releases guidelines for drug-induced liver injury – Healio

The American College of Gastroenterology has released guidelines and recommendations for physicians and health care providers to diagnosis and manage idiosyncratic drug-induced liver injury.

Diagnosis and Management of Idiosyncratic Drug-Induced

The writing group was invited by the Board of the Trustees and the Practice Parameters Committee of the American College of Gastroenterology to develop a practice guideline regarding the diagnosis and management of idiosyncratic drug-induced liver injury (DILI).

New Clinical Guidelines to Help Manage Drug-Induced Liver

The American College of Gastroenterology has issued new recommendations for physicians and other healthcare providers on the diagnosis and management of idiosyncratic drug-induced liver injury.

Drug-induced liver injury: Diagnosing (and treating) it

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49:2001-2009. 14. Tarantino G, Conca P, Basile V, et al. A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res. 2007;37:410-415. 15. Hayashi PH, Fontana RJ.

Drug-Induced Liver Injury: An Overview – U.S. Pharmacist

Mechanisms of Dili

Drug-induced liver injury: recent advances in diagnosis

Idiosyncratic drug-induced liver injury (IDILI) is a rare but potentially severe adverse drug reaction that should be considered in patients who develop laboratory criteria for liver injury secondary to the administration of a potentially hepatotoxic drug.

inPractice® – ACG Clinical Guideline: The Diagnosis and

In this ACG clinical guideline, the authors present an evidence-based approach to diagnosis and management of DILI with special emphasis on DILI due t